<DOC>
	<DOCNO>NCT00315588</DOCNO>
	<brief_summary>The purpose study reverse hyperglycemia insulin dependency , islet cell transplantation , patient type 1 diabetes mellitus stable kidney allograft .</brief_summary>
	<brief_title>Islet Cell Transplantation Patients With Type I Diabetes With Previous Kidney Transplantation</brief_title>
	<detailed_description>1 . To reverse hyperglycemia insulin dependency islet cell transplantation , patient Type 1 Diabetes Mellitus stable kidney allograft ; 2 . To eliminate incidence hypoglycemic coma unawareness islet cell transplantation ; 3 . To assess long-term function successful islet cell transplant ; 4 . To determine whether natural history microvascular , macrovascular neuropathic complication Diabetes Mellitus alter follow successful transplantation islet cell . 5 . To assess effect exenatide improve islet graft function survival subject demonstrate partial graft loss return use exogenous insulin . 6 . To assess ability exenatide improve islet survival time islet transplantation</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>1 . Patients 18 60 year age . 2 . Patients type 1 diabetes mellitus . 3 . Patients renal transplant 6 month old . 4 . Patients stable renal graft function precede 6 month , i.e . episodes rejection change serum creatinine 0.5 mg/dl baseline . 5 . Patients take tacrolimus , sirolimus +/ steroid maintenance immunosuppression least 6 month tolerate level satisfactory islet transplantation without severe complication . 6 . Patients body mass index ( BMI ) less equal 26 . 1 . Stimulated basal Cpeptide &gt; 0.3 ng/ml . 2 . Patients unstable renal function serum creatinine great 0.5 mg/dl baseline . 3 . Patients proteinuria ( albuminuria &gt; 300 mg 24 hour +/ protein ) new onset since kidney transplantation . If proteinuria albuminuria think originate native kidney ( ) exclusion criterion . 4 . Patients correct creatinine clearance less 40 . 5 . Patients weigh 80 kg . 6 . Patients body mass index ( BMI ) great 26 . 7 . Insulin requirement &gt; 1.0 U/kg/d . 8 . Anemia ( hemoglobin : male &lt; 11.0 g/dl ; female &lt; 10.0 g/dl ) . 9 . Abnormal liver function test ( consistently &gt; 1.5 x normal range ) . 10 . Unstable diabetic retinopathy . 11 . Evidence acute chronic active EpsteinBarr virus ( EBV ) infection ( IgM â‰¥ IgG ) . Patients eligible serological test becomes consistent previous exposure ( i.e . IgG &gt; IgM ) . 12 . Patients history malignancy current malignancy nonmelanomatous skin cancer , find lesion symptom screen suspicious malignancy , properly investigate rule . 13 . Patients elevation prostatespecific antigen &gt; 4 unless malignancy exclude . 14 . Patients unstable cardiovascular status . 15 . Patients active infection adequately treat , unless treatment judge necessary investigator ( include , limited , mild skin nail fungal infection ) . 16 . Patients serological evidence infection HIV , human cell lymphotropic virus 1 ( HTLV 1 ) , HTLV 2 , hepatitis B ( patient serology consistent previous vaccination history vaccination acceptable ) . 17 . Patients history and/or serological evidence hepatitis C ( patient hepatitis C , already transplant protocol continue trial ) . 18 . Positive tuberculin test ( unless proof adequate treatment latent tuberculosis provide ) . 19 . Patients active peptic ulcer disease , gallstone , hepatic hemangioma , portal hypertension . 20 . Patients pregnant breastfeeding , intend procreate . 21 . Patients sexually active female : postmenopausal , surgically sterile , use acceptable method contraception ( oral contraceptive , Norplant , DepoProvera , barrier device combine spermicidal gel acceptable ; condom use alone acceptable ) . 22 . Active alcohol substance abuse ; smoke last 6 month . 23 . Patients evidence sensitization , i.e . panel reactive antibody ( PRA ) test great 20 % . 24 . Lack updated immunization per current Centers Disease Control ( CDC ) guideline , well immunization hepatitis B , pneumococcus , influenza ( season ) , unless medically contraindicate . 25 . Patients psychogenic factor , judge psychological evaluation , make unsafe undergo islet transplantation , preclude therapeutic compliance . 26 . Patients condition circumstance would make unsafe undergo islet transplant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Islet Transplantation</keyword>
</DOC>